VenGen Participaties

VenGen Participaties is a specialized life sciences venture capital and management firm based in the Netherlands. The firm focuses on seed-stage investments and the active creation of biotechnology companies by bridging the gap between academic research and clinical development. VenGen is distinguished by its hands-on operational involvement, frequently providing interim management and strategic guidance to its portfolio entities. Notable successes associated with the firm include the founding and eventual high-value exits of Dezima Pharma to Amgen and Akarna Therapeutics to Allergan. By leveraging a deep network within the European biotech ecosystem, VenGen identifies promising therapeutic assets in areas such as metabolic and cardiovascular diseases.